Silicon Valley’s extreme life-extension proponents are quietly funding a highly controversial vision: growing non-sentient backup bodies for organ harvesting and full-body transplants.
- The Ultimate Backup Plan: Secretive biotech startups, including California-based R3 Bio, are actively researching the creation of “brainless” human clones—non-sentient bodies grown to serve as perfectly matched organ donors for their aging counterparts.
- A Stealthy Scientific Roadmap: Backed by millions from prominent venture capitalists, these companies are currently developing gene-editing techniques to create monkey “organ sacks” in the Caribbean, a critical stepping stone toward human applications.
- Ethical and Practical Chasms: Despite gaining traction among “Vitalist” immortality seekers and even drawing interest from global autocrats, the concept faces immense scientific hurdles, profound moral objections, and what experts call a magnificent “yuck factor.”
The ultimate plan to live forever doesn’t involve a magical pill or a restrictive diet; it involves a brand-new body.
For years, a stealth startup called R3 Bio, operating out of Richmond, California, has kept its true ambitions hidden from the public eye. Recently, the company emerged from the shadows, claiming to have raised funds to create non-sentient monkey “organ sacks” as a cruelty-free alternative to animal testing. Supported by heavy-hitting investors like billionaire Tim Draper, the Singapore-based fund Immortal Dragons, and LongGame Ventures, the pitch sounded like a pragmatic leap in biotech.
But there is a much darker, ethically charged underbelly to this story—one that the founders fiercely tried to keep out of the headlines. The true endgame, aggressively pitched to exclusive circles of life-extension enthusiasts, involves gestating “brainless human clones” to serve as living, breathing organ repositories.
Imagine a biological carbon copy of yourself, engineered to lack a functioning brain, kept alive solely on life support until your original body fails and you need a fresh liver, kidney, or—hypothetically—a complete body transplant. It is a concept that sounds ripped from a dystopian science fiction thriller, but to a radical fringe of Silicon Valley, it is the most logical cure for death.
The Blueprint for a “Brainless” Clone
At the center of this controversy is R3 Bio’s founder, John Schloendorn, a biotech outsider with a PhD who previously made waves running a DIY lab out of his garage. Along with co-founder Alice Gilman, Schloendorn has been quietly selling a vision that leaves some listeners reeling. One anonymous attendee of an R3 presentation compared the medically graphic pitch to a “close encounter of the third kind” crossed with Dr. Strangelove.
The scientific inspiration for R3’s macabre proposal stems from a tragic human birth defect known as hydranencephaly, where children are born missing most of their cortical hemispheres. By showing potential investors medical scans of these nearly empty skulls, Schloendorn argues that a human body can successfully grow and survive without higher consciousness.
Because artificial wombs do not yet exist, the initial roadmap is as pragmatic as it is unsettling. The first generations of these non-sentient clones would have to be carried to term by paid female surrogates. Only in the distant future, the founders speculate, could one brainless clone physically give birth to another.
To circumvent the staggering failure rates of traditional cloning—which has plagued science since Dolly the sheep in 1996—R3 has outlined complex genetic wiring diagrams. Leaked documents reveal plans involving a protein called histone demethylase to erase cellular genetic memory, alongside a mysterious “birthing fix” to overcome fatal placental defects.
The Vitalist Underground
Why the intense secrecy? The architects of this technology are deeply afraid of public backlash.
This extreme life-extension community, often aligning with a philosophy known as “Vitalism,” believes society must redirect its resources toward achieving unlimited human lifespans. They frequently gather at off-the-record events, like the $70,000-per-ticket Abundance Longevity summit in Boston organized by Peter Diamandis. There, under the banner of “Full Body Replacement,” Schloendorn and Gilman stood before an image of a cloning needle, discussing personal clones for spare organs.
Entrepreneur Kris Borer, presenting a longevity roadmap to the Vitalist community last year, estimated that creating a proof-of-concept human clone lacking a neocortex would cost a relatively paltry $40 million. However, he explicitly warned against going public too soon. “We are not going to start with Let’s clone you and give you a body,” Borer advised. “We are going to start with Let’s solve the organ shortage. Eventually people will warm up to it, and then we can go to the more hardcore stuff.”
R3 Bio is not the only player in this shadowy arena. Justin Rebo, an anti-aging researcher and sometime collaborator of Schloendorn’s, heads Kind Biotechnology in New Hampshire. Kind Bio’s patent applications feature startling cartoon renderings of fleshy, duffel-bag-like “organ sacks” connected to tubes. Using CRISPR gene editing, Rebo’s team is attempting to delete genes in embryos to create animals—and potentially humans—that possess a “complete lack of ability to feel, think, or sense the environment.”
Dictators, Cryonics, and the Market for Immortality
The target demographic for such a controversial and phenomenally expensive procedure would naturally skew toward the ultra-rich and the ultra-powerful. It is a reality not lost on the investors or the global elite.
In a recently intercepted hot-mic moment, Russian President Vladimir Putin was heard discussing life extension with Chinese leader Xi Jinping. “The longer you live, the younger you become, and [you can] even achieve immortality,” Putin remarked.
Will Harborne, chief investment officer of LongGame Advisors (which injected $1 million into R3), openly discussed this geopolitical angle on a podcast. “If you were the dictator of some country and wanted a clone of yourself, you can already go grow one,” Harborne stated, outlining how an autocrat could theoretically raise a clone to age 18 and harvest its body. He quickly added that stunting the clone’s brain is necessary because “we don’t want to kill other people to live forever.”
Beyond autocrats, the cryogenic preservation industry represents another massive potential market. Anders Sandberg, a prominent Swedish transhumanist, notes that many cryonics patients opt for the cheaper “head only” preservation. “There might be a market for having an extra cloned body,” Sandberg suggests, theoretically allowing a frozen head to be thawed and attached to a fresh, cloned torso in the future.
The Scientific and Moral Reality Check
Despite the millions of dollars flowing into these stealth projects and the enthusiastic support from figures like ARPA-H program manager Jean Hébert and longevity provocateur Aubrey de Grey, mainstream science remains fiercely skeptical—and morally appalled.
“It sounds crazy, in my opinion,” says Jose Cibelli, a pioneering cloning researcher at Michigan State University. “How do you demonstrate safety? What is safety when you’re trying to create an abnormal human?” Furthermore, Cibelli points out the practical absurdity of the current plan: “You’d have to convince a woman to carry a fetus that is going to be abnormal.”
The actual medical viability of “replacement” is also highly suspect. While swapping a failing heart sounds logically akin to replacing a car part, there is zero clinical evidence that receiving organs from a younger twin extends total lifespan. Complete body transplants are even more fantastical. When Russian surgeons recently attempted to sever and reattach a pig’s head, the animal was paralyzed due to the severed spinal cord and had to be euthanized within hours. As controversial surgeon Sergio Canavero notes, biomechanical compatibility makes transplanting an adult head onto a toddler-sized clone physically impossible.
Then there is the profound ethical paradox of consciousness. While futurists like Sandberg believe a genetically engineered lack of a neocortex guarantees an absence of suffering, neuroscientists vehemently disagree. The brain stem alone, which would be required to keep the body’s autonomous functions running, may produce a basic form of consciousness. If that is true, harvesting organs from these clones would not be a medical miracle; it would be, as Canavero bluntly puts it, “a homicide.”
For now, companies like R3 vehemently deny any current plans to clone humans or create brain-damaged primates, retreating behind statements of “feasibility research.” Yet, the financial paper trails, patent filings, and closed-door presentations tell a different story. As the pursuit of extreme longevity pushes the boundaries of biotechnology, the line between science fiction and science fact is blurring, leaving society to grapple with what Sandberg aptly describes as a “magnificent yuck factor.”